← Back to front page
Oceania · Financial press · Australian Financial Review

Novo Nordisk says Wegovy pill to cost up to $395 per month

Published by Australian Financial Review · Australia 14 h ago
Novo Nordisk says Wegovy pill to cost up to $395 per month
Australian Financial Review

Detailed summary

The Danish drugmaker has announced the recommended pricing for its Wegovy tablet that is expected to go on sale in Australia by the end of the year.

The first pill version of GLP-1 weight-loss drugs to be sold in Australia will cost between $260 and $395 per month depending on the dosage, a similar price to the monthly injections currently available.

Danish drugmaker Novo Nordisk on Friday announced the recommended pricing for its Wegovy tablet that is expected to go on sale in Australia by the end of the year.

Opening of the article, excerpted from Australian Financial Review. To read the rest, open the article on the publisher's site.

Read the full article on Australian Financial Review Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.afr.com)